BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) posted its quarterly earnings results on Friday. The company reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.03, Zacks reports. The business had revenue of $3.15 billion for the quarter, compared to analyst estimates of $2.99 billion. BrightSpring Health Services had a net margin of 0.49% and a return on equity of 7.76%. The firm's revenue for the quarter was up 15.3% on a year-over-year basis. During the same quarter last year, the business posted $0.10 EPS. BrightSpring Health Services updated its FY 2025 guidance to EPS.
BrightSpring Health Services Stock Down 2.5%
Shares of NASDAQ BTSG traded down $0.52 during mid-day trading on Friday, reaching $20.13. 3,923,959 shares of the company's stock traded hands, compared to its average volume of 2,035,273. BrightSpring Health Services has a 1-year low of $10.15 and a 1-year high of $25.57. The stock has a market cap of $3.54 billion, a P/E ratio of 71.96 and a beta of 2.30. The business has a 50-day simple moving average of $21.96 and a 200 day simple moving average of $20.47. The company has a debt-to-equity ratio of 1.48, a current ratio of 1.73 and a quick ratio of 1.37.
Insider Transactions at BrightSpring Health Services
In other BrightSpring Health Services news, insider Jon B. Rousseau sold 531,840 shares of the stock in a transaction that occurred on Thursday, June 12th. The shares were sold at an average price of $21.75, for a total value of $11,567,520.00. Following the sale, the insider directly owned 1,184,133 shares in the company, valued at $25,754,892.75. This represents a 30.99% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, major shareholder Phoenix Aggregator L.P. Kkr sold 2,100,000 shares of the stock in a transaction on Tuesday, June 24th. The stock was sold at an average price of $21.15, for a total transaction of $44,415,000.00. Following the completion of the transaction, the insider directly owned 77,096,337 shares in the company, valued at $1,630,587,527.55. The trade was a 2.65% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 15,919,941 shares of company stock valued at $337,025,856 over the last ninety days. 3.40% of the stock is currently owned by insiders.
Hedge Funds Weigh In On BrightSpring Health Services
A number of large investors have recently added to or reduced their stakes in BTSG. Millennium Management LLC boosted its stake in shares of BrightSpring Health Services by 0.3% during the 1st quarter. Millennium Management LLC now owns 577,885 shares of the company's stock valued at $10,454,000 after purchasing an additional 1,967 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of BrightSpring Health Services by 11.0% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 147,280 shares of the company's stock worth $2,664,000 after acquiring an additional 14,586 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in BrightSpring Health Services by 5.8% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 32,429 shares of the company's stock valued at $587,000 after purchasing an additional 1,780 shares in the last quarter. Finally, AQR Capital Management LLC purchased a new stake in shares of BrightSpring Health Services in the first quarter valued at $276,000.
Analysts Set New Price Targets
A number of brokerages have weighed in on BTSG. Wall Street Zen lowered shares of BrightSpring Health Services from a "strong-buy" rating to a "buy" rating in a research report on Saturday, July 26th. TD Cowen started coverage on shares of BrightSpring Health Services in a report on Monday, June 23rd. They set a "buy" rating and a $37.00 price target on the stock. Mizuho set a $26.00 price target on shares of BrightSpring Health Services in a report on Monday, May 5th. Wells Fargo & Company lifted their price target on shares of BrightSpring Health Services from $25.00 to $27.00 and gave the stock an "overweight" rating in a report on Tuesday, May 13th. Finally, Morgan Stanley lifted their price target on shares of BrightSpring Health Services from $20.00 to $25.00 and gave the stock an "overweight" rating in a report on Friday, May 9th. One equities research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $24.90.
Get Our Latest Stock Analysis on BTSG
About BrightSpring Health Services
(
Get Free Report)
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider BrightSpring Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.
While BrightSpring Health Services currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.